Unlock the algorithms: regulation of adaptive algorithms in reproduction
In the USA, the Food and Drug Administration plans to regulate artificial intelligence and machine learning software systems as medical devices to improve the quality, consistency, and transparency of their performance across specific age, racial, and ethnic groups. Embryology procedures do not fall...
Gespeichert in:
| Veröffentlicht in: | Fertility and sterility Jg. 120; H. 1; S. 38 |
|---|---|
| 1. Verfasser: | |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.07.2023
|
| Schlagworte: | |
| ISSN: | 1556-5653, 1556-5653 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | In the USA, the Food and Drug Administration plans to regulate artificial intelligence and machine learning software systems as medical devices to improve the quality, consistency, and transparency of their performance across specific age, racial, and ethnic groups. Embryology procedures do not fall under the federal regulation of "CLIA 88." They are not tests per se; they are cell-based procedures. Likewise, many add-on procedures related to embryology, such as preimplantation genetic testing, are considered "laboratory-developed tests" and are not subject to Food and Drug Administration regulation at present. Should predictive artificial intelligence algorithms in reproduction be considered medical devices or laboratory-developed tests? Certain indications certainly carry a higher risk, such as medication dosage, where the consequences of mismanagement could be severe, whereas others, such as embryo selection, are noninterventional (selecting from a patient's own embryos and the course of treatment does not change) and present little to no risk. The regulatory landscape is complex, involving data diversity and performance, real-world evidence, cybersecurity, and postmarket surveillance. |
|---|---|
| AbstractList | In the USA, the Food and Drug Administration plans to regulate artificial intelligence and machine learning software systems as medical devices to improve the quality, consistency, and transparency of their performance across specific age, racial, and ethnic groups. Embryology procedures do not fall under the federal regulation of "CLIA 88." They are not tests per se; they are cell-based procedures. Likewise, many add-on procedures related to embryology, such as preimplantation genetic testing, are considered "laboratory-developed tests" and are not subject to Food and Drug Administration regulation at present. Should predictive artificial intelligence algorithms in reproduction be considered medical devices or laboratory-developed tests? Certain indications certainly carry a higher risk, such as medication dosage, where the consequences of mismanagement could be severe, whereas others, such as embryo selection, are noninterventional (selecting from a patient's own embryos and the course of treatment does not change) and present little to no risk. The regulatory landscape is complex, involving data diversity and performance, real-world evidence, cybersecurity, and postmarket surveillance.In the USA, the Food and Drug Administration plans to regulate artificial intelligence and machine learning software systems as medical devices to improve the quality, consistency, and transparency of their performance across specific age, racial, and ethnic groups. Embryology procedures do not fall under the federal regulation of "CLIA 88." They are not tests per se; they are cell-based procedures. Likewise, many add-on procedures related to embryology, such as preimplantation genetic testing, are considered "laboratory-developed tests" and are not subject to Food and Drug Administration regulation at present. Should predictive artificial intelligence algorithms in reproduction be considered medical devices or laboratory-developed tests? Certain indications certainly carry a higher risk, such as medication dosage, where the consequences of mismanagement could be severe, whereas others, such as embryo selection, are noninterventional (selecting from a patient's own embryos and the course of treatment does not change) and present little to no risk. The regulatory landscape is complex, involving data diversity and performance, real-world evidence, cybersecurity, and postmarket surveillance. In the USA, the Food and Drug Administration plans to regulate artificial intelligence and machine learning software systems as medical devices to improve the quality, consistency, and transparency of their performance across specific age, racial, and ethnic groups. Embryology procedures do not fall under the federal regulation of "CLIA 88." They are not tests per se; they are cell-based procedures. Likewise, many add-on procedures related to embryology, such as preimplantation genetic testing, are considered "laboratory-developed tests" and are not subject to Food and Drug Administration regulation at present. Should predictive artificial intelligence algorithms in reproduction be considered medical devices or laboratory-developed tests? Certain indications certainly carry a higher risk, such as medication dosage, where the consequences of mismanagement could be severe, whereas others, such as embryo selection, are noninterventional (selecting from a patient's own embryos and the course of treatment does not change) and present little to no risk. The regulatory landscape is complex, involving data diversity and performance, real-world evidence, cybersecurity, and postmarket surveillance. |
| Author | Curchoe, Carol Lynn |
| Author_xml | – sequence: 1 givenname: Carol Lynn surname: Curchoe fullname: Curchoe, Carol Lynn email: carolc@aivf.co organization: ART Compass, an AIVF Technology, Newport Beach, California. Electronic address: carolc@aivf.co |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37217091$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNz01PwzAMBuAIDbEP-AsoRy4tcdKkCTc0AUOaxIWdqyxNto42GU2KxL-niCHtYvvwyPY7RxMfvEUIA8mBgLg_5M72ycc01pwSynLCc-D0As2Ac5FxwdnkbJ6ieYwHQoiAkl6hKSsplETBDK02vg3mA6e9xbrdhb5J-y4-4N7uhlanJngcHNa1Pqbm65zgxo_o2Id6ML_sGl063UZ7c-oLtHl-el-usvXby-vycZ2ZgkHKwBhVWKK1MrWWQlIqC2rEVjoQHGitwBLjrNKm1Jpx6qRxXDFtaV3Y8WW6QHd_e8fTn4ONqeqaaGzbam_DECsqQRLOlGAjvT3RYdvZujr2Taf77-o_Pf0BldtikA |
| CitedBy_id | crossref_primary_10_3390_jcm14093127 crossref_primary_10_46989_001c_137620 crossref_primary_10_1186_s12911_025_02884_1 crossref_primary_10_1016_j_xfre_2024_09_002 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2023 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.fertnstert.2023.05.152 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1556-5653 |
| ExternalDocumentID | 37217091 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K -~X .1- .55 .FO .GJ 0R~ 1B1 1P~ 1~5 29H 34R 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 85S AAEDT AAEDW AAFWJ AALRI AAQFI AAQXK AAXUO AAYWO ABCQX ABFRF ABJNI ABLJU ABMAC ABWVN ACGFO ACIUM ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO ADVLN AEFWE AENEX AEUPX AEVXI AFCTW AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGQPQ AI. AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BELOY C5W CGR CS3 CUY CVF DU5 EBS ECM EFJIC EFKBS EIF EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N9A NPM NQ- O9- OK1 OQ. P2P PH~ R2- RIG ROL RPZ SDP SEL SES SEW SSZ UNMZH UV1 VH1 W2D X7M XH2 XJT XPP YOC YZZ Z5R ZGI ZXP ~S- 7X8 |
| ID | FETCH-LOGICAL-c431t-1cc94e0aa9cda86822842c6b8f16512d91e0cfe9ac7aa352f8cf593ae2d4e7092 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 4 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001023428800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1556-5653 |
| IngestDate | Sat Sep 27 18:45:54 EDT 2025 Mon Jul 21 05:41:20 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | regulatory affairs FDA Artificial intelligence medical AI |
| Language | English |
| License | Copyright © 2023 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c431t-1cc94e0aa9cda86822842c6b8f16512d91e0cfe9ac7aa352f8cf593ae2d4e7092 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 37217091 |
| PQID | 2818053963 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2818053963 pubmed_primary_37217091 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-07-00 20230701 |
| PublicationDateYYYYMMDD | 2023-07-01 |
| PublicationDate_xml | – month: 07 year: 2023 text: 2023-07-00 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Fertility and sterility |
| PublicationTitleAlternate | Fertil Steril |
| PublicationYear | 2023 |
| SSID | ssj0006172 |
| Score | 2.4469025 |
| SecondaryResourceType | review_article |
| Snippet | In the USA, the Food and Drug Administration plans to regulate artificial intelligence and machine learning software systems as medical devices to improve the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 38 |
| SubjectTerms | Algorithms Artificial Intelligence Humans Machine Learning Reproduction Software |
| Title | Unlock the algorithms: regulation of adaptive algorithms in reproduction |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37217091 https://www.proquest.com/docview/2818053963 |
| Volume | 120 |
| WOSCitedRecordID | wos001023428800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDI6AIcSF92O8FCSugb6bcEEIMe3Aph2YtNvk5gET0I518Pux205wQULiklOSVrZjf43dz4xdZKAzT7lAOJmFIlImFhJiPO6Z0TGuMeAqdv2HtN-Xo5EaNBduZVNWufCJlaM2haY78itiLUKDQXu5mb4L6hpF2dWmhcYya4UIZaikKx19s4VTdK74UuNEIHAJm0qeur7L2RmRtOJ4SS3Eib_Tp9-PfgOaVcDpbP73VbfYRgM1-W1tG9tsyeY7bK3XJNN3WXeYYyR74QgBObw-4Q7z57fyms_q9vSoMF44Dgam5BJ_TOGTnBMZZsUVi9P22LBz_3jXFU1jBaERL8yFr7WKrAegUBcyQYwgo0AnmXR-ggDAKN962lkFOgVAhOakdrEKwQYmsqmngn22khe5PWRcUt4wBS-WKUReZJXxQ9yaepmBM55ss_OFjMZouJSNgNwWH-X4W0ptdlALejytGTbGIX6X4nP8oz-sPmbrpL-6hPaEtRweW3vKVvXnfFLOziqLwLE_6H0BHm7CHQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unlock+the+algorithms%3A+regulation+of+adaptive+algorithms+in+reproduction&rft.jtitle=Fertility+and+sterility&rft.au=Curchoe%2C+Carol+Lynn&rft.date=2023-07-01&rft.eissn=1556-5653&rft.volume=120&rft.issue=1&rft.spage=38&rft_id=info:doi/10.1016%2Fj.fertnstert.2023.05.152&rft_id=info%3Apmid%2F37217091&rft_id=info%3Apmid%2F37217091&rft.externalDocID=37217091 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-5653&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-5653&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-5653&client=summon |